scispace - formally typeset
Journal ArticleDOI

Enhanced osteoporotic bone regeneration by strontium-substituted calcium silicate bioactive ceramics.

Reads0
Chats0
TLDR
In vivo experiments revealed that SrCS dramatically stimulated bone regeneration and angiogenesis in a critical sized OVX calvarial defect model, and the enhanced bone regeneration might be attributed to the modulation of osteogenic differentiation of endogenous mesenchymal stem cells (MSCs) and the inhibition of osteoclastogenesis, accompanying with the promotion of the angiogenic activity of endothelial cells (ECs).
About
This article is published in Biomaterials.The article was published on 2013-12-01. It has received 295 citations till now. The article focuses on the topics: Bone regeneration & Bone resorption.

read more

Citations
More filters
Journal ArticleDOI

Nanostructured monticellite: An emerging player in tissue engineering

TL;DR: In this paper, a novel calcium silicate bioceramic (monticellite) was synthesized by sol-gel method and heat-treated at low temperature (1350°C).
Journal ArticleDOI

Strontium-Substituted Dicalcium Silicate Bone Cements with Enhanced Osteogenesis Potential for Orthopaedic Applications.

TL;DR: The Sr-C2S bone cements possessed good in vitro bioactivity by inducing apatite formation in simulated body fluid (SBF) within 7 days and might be a bioactive self-setting material with enhanced biological performance and holds the prospect for application in the bone regeneration area.
Journal ArticleDOI

Immunohistochemical evaluation after Sr-enriched biphasic ceramic implantation in rabbits femoral neck: comparison of seven different bone conditions

TL;DR: It is concluded that Sr-enriched biomaterials induce higher potential to improve bone regeneration than pure bioceramics in constant osteoporosis of femoral neck bone.
Journal ArticleDOI

Does Local Application of Strontium Increase Osteogenesis and Biomaterial Osteointegration in Osteoporotic and Other Bone Tissue Conditions: Review of Literature

TL;DR: An overview about strontium, its mechanisms of action in bone tissue and initiated changes of bone remodeling within biomaterials is provided.
Journal ArticleDOI

Polymeric coating on β-TCP scaffolds provides immobilization of small extracellular vesicles with surface-functionalization and ZEB1-Loading for bone defect repair in diabetes mellitus

TL;DR: In this paper , a hyaluronic acid (HA)/poly-L-lysine (PLL) layer-by-layer self-assembly coating on β-TCP (β-tricalcium phosphate) scaffolds providing immobilization of modularized engineered sEVs (with RGDfC) surface functionalization and ZEB1 loading) to facilitate bone defect regeneration under DM conditions.
References
More filters
Journal ArticleDOI

The biology of VEGF and its receptors.

TL;DR: Vascular endothelial growth factor (VEGF) is a key regulator of physiological angiogenesis during embryogenesis, skeletal growth and reproductive functions and is implicated in pathologicalAngiogenesis associated with tumors, intraocular neovascular disorders and other conditions.
Journal ArticleDOI

Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

TL;DR: Nonenzymatic mechanisms that impact MAP kinase functions and findings from gene disruption studies are highlighted and particular emphasis is on ERK1/2.
Journal ArticleDOI

Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases

TL;DR: Multicellular organisms have three well-characterized subfamilies of mitogen-activated protein kinases (MAPKs) that control a vast array of physiological processes, and inhibitors of these enzymes are being explored as anticancer agents.
Journal ArticleDOI

Osteoporosis: now and the future

TL;DR: Novel treatment strategies have been developed that aim to inhibit excessive bone resorption and increase bone formation and the most promising novel treatments include denosumab, a monoclonal antibody for receptor activator of NF-κB ligand; odanacatib, a specific inhibitor of the osteoclast protease cathepsin K; and antibodies against the proteins sclerostin and dickkopf-1, two endogenous inhibitors of bone formation.
Related Papers (5)